Wednesday, October 7, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 3, 2025

North America Health and Wellness Market Report 2025-2033

View original at globenewswire.com
North America Health and Wellness Market Report 2025-2033 Dublin, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The "North America Health and Wellness Market Report by Product Type, Functionality, Country and Company Analysis, 2025-2033" report has been added to ResearchAndMarkets.com's offering…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The North America Health and Wellness industry is transitioning from a reactive healthcare model to a proactive, lifestyle-driven approach

    80% confidence
  • The market will grow with a CAGR of 3.05% from 2025 to 2033

    80% confidence
  • The post-pandemic era has accelerated shift toward health and wellness with heightened focus on immunity, mental health, and stress management

    80% confidence
  • Organizations are increasingly recognizing the link between employee well-being, productivity, and business performance

    80% confidence
  • The United States is leading in innovation and digital health adoption, while Canada experiences steady growth driven by government initiatives and preventive healthcare awareness

    80% confidence
  • The market is projected to witness steady growth, driven by increasing consumer awareness, rising healthcare expenditure, and a strong focus on preventive health and holistic well-being

    80% confidence
  • The North America Health and Wellness Market is expected to reach US$ 1.74 trillion by 2033 from US$ 1.33 trillion in 2024

    80% confidence
  • The lack of strict oversight in some sub-segments, particularly dietary supplements and natural remedies, increases the risk of counterfeit or low-quality products

    80% confidence
  • High product pricing, regulatory complexities, and disparities in accessibility between urban and rural populations are major industry challenges

    80% confidence
  • Premium pricing of organic foods, supplements, and fitness programs often restricts accessibility for lower-income groups

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,351 source documents archived
Query this data → isubstrate.com